MDLIVE Review 2026
Reviewed August 5, 2026 · Brand-name FDA-approved only — Zepbound, Wegovy, Saxenda and the non-GLP-1 Contrave
Visit MDLIVE WebsiteOverview
MDLIVE, an Evernorth company, is one of the largest established virtual care organisations in the country, and its weight-management offering reflects that scale and conservatism. It names its medications plainly — Zepbound, Wegovy, Saxenda and the non-GLP-1 Contrave, all FDA-approved, with no compounded product anywhere — and prescribes them through Primary Care Routine Care visits at the doctor's discretion rather than through a dedicated weight-loss funnel. Access is broad: available anywhere in the United States and Puerto Rico, with visits costing as little as $0 if you have MDLIVE through your health plan or employer. Uncommonly, MDLIVE publishes precisely which states are excluded from anti-obesity medication prescribing: Florida, Louisiana, Mississippi and New Jersey. That specificity is more useful than the vague 'availability varies' language most competitors use.
Medications Offered
Brand-name or compounded: Brand-name FDA-approved only — Zepbound, Wegovy, Saxenda and the non-GLP-1 Contrave
- Zepbound (brand-name tirzepatide) — FDA-approved for chronic weight management
- Wegovy (brand-name semaglutide) — FDA-approved for chronic weight management
- Saxenda (brand-name liraglutide) — FDA-approved for chronic weight management
- Contrave (naltrexone/bupropion) — FDA-approved non-GLP-1 option
- Prescribed through Primary Care Routine Care visits, at the doctor's discretion
- No compounded medication offered
Consultation Process
Check whether you have MDLIVE through a plan
If you have MDLIVE services through your health plan or employer, appointments could cost as little as $0. You can also create an account directly.
Book a Primary Care Routine Care visit
Anti-obesity medications are prescribed only through Primary Care Routine Care visits, not through an urgent-care or dedicated weight-loss pathway.
Physician assessment
Medication is prescribed at the doctor's discretion after clinical assessment.
Prescription to your pharmacy
Prescriptions go to your pharmacy, where your pharmacy benefit applies to the FDA-approved medication.
Eligibility
- Not published in detail — prescribed at the doctor's discretion
- Must be seen through a Primary Care Routine Care visit
- Anti-obesity medications unavailable in Florida, Louisiana, Mississippi and New Jersey
- Adults; standard GLP-1 contraindications apply
Provider Involvement
Requiring a Primary Care Routine Care visit rather than a dedicated weight-loss funnel is a meaningful clinical choice: it puts weight management inside a general primary care encounter where other conditions and medications get considered too. Prescribing is explicitly at the doctor's discretion, which means approval is not the default.
Lab Requirements
Not published. Because MDLIVE operates through insurance and primary care, labs would be ordered and billed through conventional channels rather than a cash-pay telehealth arrangement.
Pharmacy Fulfillment
MDLIVE does not dispense. Prescriptions go to your own pharmacy, where you receive manufacturer FDA-approved product under your pharmacy benefit. No compounding step exists anywhere in this chain.
Shipping Frequency
Not applicable — you fill and refill at your own pharmacy on its normal schedule.
Membership Fees vs. Medication Fees
Membership fees
None specific to weight management. Visit costs depend on your coverage — as little as $0 with an eligible health plan or employer.
Medication fees
- Visits: as little as $0 with an eligible health plan or employer
- Medication: billed separately by your pharmacy, cost not published
- Cash-pay visit pricing is not clearly published for weight management
Cancellation & Refund Policy
Cancellation
Not applicable in a subscription sense — MDLIVE bills per visit or through your plan.
Refunds
Not published; standard plan and visit billing practices apply.
Insurance
Insurance and employer coverage are central to MDLIVE's model — appointments could cost as little as $0 if you have MDLIVE through your health plan or employer. Because it prescribes only FDA-approved medication to your own pharmacy, your pharmacy benefit genuinely applies to the drug, which is structurally impossible at compounded platforms.
HSA / FSA
Not stated specifically. Visit fees and prescriptions are a straightforward HSA/FSA case with documentation.
See our GLP-1 insurance and HSA/FSA guide for how reimbursement works in practice.
Support Services
- Primary care visits covering weight management alongside other conditions
- Health plan and employer integration with $0 visit potential
- Nationwide plus Puerto Rico availability
- Broader MDLIVE platform covering urgent care, dermatology and behavioural health
- Backed by Evernorth
State Availability
Available anywhere in the United States and Puerto Rico for general services, with one specific and clearly published restriction: anti-obesity medications are not available in Florida, Louisiana, Mississippi or New Jersey. Publishing exact exclusions is better practice than the vague language most competitors use.
Pros
- Names its medications: Zepbound, Wegovy, Saxenda and Contrave — all FDA-approved
- Visits can cost as little as $0 with an eligible health plan or employer
- Available anywhere in the United States and Puerto Rico
- Publishes exactly which states are excluded from anti-obesity medication
- Part of Evernorth, a major established healthcare organisation
- No compounded medication
Cons
- Anti-obesity medications are not available in Florida, Louisiana, Mississippi or New Jersey
- Weight medication is only prescribed through Primary Care Routine Care visits, at the doctor's discretion
- Medication cost is separate and not published
- No published eligibility criteria or lab requirements
- Cash-pay pricing for visits is not clearly published
Who MDLIVE May Be Best For
- Patients who already have MDLIVE through an employer or health plan
- People who want FDA-approved medication on their pharmacy benefit
- Patients who want weight management inside general primary care
- Anyone in Puerto Rico or a state smaller platforms do not serve
Limitations
- Not available for anti-obesity medication in FL, LA, MS or NJ
- Requires a Primary Care Routine Care visit specifically
- Prescribing is at the doctor's discretion — approval is not assured
- Medication cost is separate and unpublished
- Cash-pay visit pricing for weight management is unclear
Reputation & Trust
MDLIVE is part of Evernorth, operating under conventional health-plan contracts and clinical governance rather than direct-to-consumer telehealth norms. Naming its exact medications, refusing compounded product, requiring a primary care visit and publishing precise state exclusions are all signals of an organisation behaving like a healthcare company rather than a prescription funnel.
What Makes MDLIVE Different
- Names exact FDA-approved medications with no compounded product
- Visits from $0 with an eligible health plan or employer
- Nationwide plus Puerto Rico coverage
- Publishes precise state exclusions for anti-obesity medication
- Weight management handled within primary care rather than a separate funnel
Our Verdict
MDLIVE earns 4/5 for behaving like a healthcare organisation rather than a prescription funnel. It names exactly which FDA-approved medications it prescribes, sells no compounded product, routes weight management through a primary care visit where the rest of your health gets considered, covers the whole US plus Puerto Rico, and publishes precisely which four states are excluded — a level of specificity most competitors avoid. If you already have MDLIVE through an employer or health plan, visits can cost $0 and your pharmacy benefit applies to the drug, which is close to unbeatable. The limits are that medication cost is unpublished and outside its control, cash-pay visit pricing is unclear, and prescribing is explicitly discretionary. Check your benefits before paying anyone else.
Alternatives to MDLIVE
The closest comparable large-scale plan-based virtual care provider.
Insurance-accepting primary care with published visit pricing and eligibility criteria.
400+ insurance plans with brand-name-only prescribing in all 50 states.
Accepts Medicare and Medicaid with published self-pay visit pricing.
Compare more options on our best online GLP-1 providers and cheapest GLP-1 programs pages.
Frequently Asked Questions
Which weight-loss medications does MDLIVE prescribe?
MDLIVE names Zepbound, Wegovy, Saxenda and Contrave — all FDA-approved, with no compounded products. They are prescribed through Primary Care Routine Care visits at the doctor's discretion.
Is MDLIVE available in my state?
MDLIVE states it is available anywhere in the United States and Puerto Rico, but that anti-obesity medications specifically are not available in Florida, Louisiana, Mississippi or New Jersey. That exclusion is published clearly, which is more than most competitors do.
How much does MDLIVE cost?
If you have MDLIVE through your health plan or employer, appointments could cost as little as $0. Medication is billed separately by your pharmacy and its cost is not published — with FDA-approved product, your pharmacy benefit can apply.
Can I book a weight-loss-specific appointment?
No. MDLIVE prescribes anti-obesity medications through Primary Care Routine Care visits only, not through a dedicated weight-loss pathway. That means your weight is assessed in the context of your broader health rather than in isolation.
Important Notes & Warnings
- Anti-obesity medications are NOT available through MDLIVE in Florida, Louisiana, Mississippi or New Jersey.
- Prescribing is at the doctor's discretion through a Primary Care Routine Care visit — approval is not assured.
- Medication cost is separate from the visit and is not published.
- Cash-pay visit pricing for weight management is not clearly published.
- Contraindicated with a personal or family history of medullary thyroid carcinoma or MEN2.
Sources
- MDLIVE website and weight management information, mdlive.com (accessed August 2026)
- Google Search results collected via Bright Data SERP API, August 2026
Medical Disclaimer
This review is for informational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. GLP-1 medications are prescription drugs with real risks and contraindications. Only a licensed clinician who has evaluated you can decide whether any medication is appropriate. Talk to a healthcare provider before starting, changing, or stopping any treatment, and call emergency services for urgent symptoms.
Facts in this review were compiled from the provider's own public website and public search results as of August 5, 2026. Prices, medication availability, pharmacy partners, and policies change frequently and vary by state — verify everything directly with the provider before purchasing.
This page contains affiliate links. We may earn a commission from qualifying purchases at no additional cost to you.